Hello,
Welcome to Dispensed, $4 I'm Kimberly Leonard, and I'm BI's healthcare reporter $4.
I'm guest hosting our newsletter today from Philadelphia. Thanks to a quick turnaround in coronavirus testing provided for free in Washington, DC, I was able to get cleared before visiting family here.
It's a huge relief to have that peace of mind. Even though I wasn't having symptoms, I wanted to be careful given data showing that $4 who've been infected haven't gotten sick.
Having said all that, I was getting whiplash this week when I read about the changing guidance from the Trump administration on testing. Our reporters covered it: First the administration said people who'd been exposed to the coronavirus but weren't having symptoms $4, and then $4.
If you know what happened behind the scenes, I hope you'll tell me about it at kleonard@businessinsider.com.
There's tons more news on the coronavirus pandemic, but we also covered other business developments this week. Here's a quick look at some of our stories:
A quick reminder: You can now get our newsletter every day. Subscribe here for your daily dose of healthcare news from the Business Insider team. >$4
>$4
For my latest story I spent some time thinking about the last few year's of Trump's presidency — the changes his administration made to the Affordable Care Act; the initiatives on HIV, opioid addiction, and kidney care; and of course the handling of the coronavirus pandemic. Who were the people who shaped and handled the details of the various policies?
There are of course the obvious, such as $4, Vice President Mike Pence, and $4, administrator of the Centers for Medicare and Medicaid Services. But I also identified people close to the administration that you probably haven't heard of. They're the people working behind the scenes who are on the front lines of handling the nitty gritty details of policy making.
Is my list missing anyone? Let me know at kleonard@businessinsider.com.
Are you new to Business Insider's paywall? $4.
The shot was found to be safe and created an immune response in trial participants who were older than 55. The data is important because elderly Americans are $4 Some vaccines don't work as well in older people.
Moderna is currently running a late-stage trial, testing 30,000 people to see whether its vaccine can prevent infection or disease. Moderna CEO Stephane Bancel told Business Insider that $4.
